Department of Supportive Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
Hemby Family Endowed Chair in Supportive Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
Nutr Clin Pract. 2024 Dec;39(6):1452-1463. doi: 10.1002/ncp.11233. Epub 2024 Oct 29.
Malnutrition is common in hospitalized patients with cancer and adversely affects clinical outcomes. We evaluated the prevalence of malnutrition risk, dietitian-identified malnutrition (DIMN), and physician-diagnosed malnutrition (PDMN) at admission.
This retrospective study included adults diagnosed with a stage I-IV solid tumor malignancy and admitted to Atrium Health Carolinas Medical Center from January 2016 to May 2019. Malnutrition risk was determined by a score ≥2 on the Malnutrition Screening Tool (MST) administered by a registered nurse during the intake process. Registered dietitian nutritionist (RDN) assessments were reviewed for DIMN and grade (mild, moderate, or severe). PDMN included malnutrition International Classification of Diseases, Tenth Revision codes in the discharge summary. Univariate models were estimated; multivariate logistic regression models identified associations between clinicodemographic factors and malnutrition prevalence with stepwise selection.
A total of 5143 patients were included. Median age was 63 (range 18-102) years, 48% were female, 70% were White, and 24% were Black. Upper gastrointestinal (21%), thoracic (18%), and genitourinary (18%) cancers were most common. A total of 28% had stage IV disease. MST scores were available for 4085 (79%); 1005 of 4085 (25%) were at malnutrition risk. Eleven percent (n = 557) had malnutrition coded by a physician or documented by an RDN; 4% (n = 223) of these were identified by both clinicians, 4% (n = 197) by RDNs only, and 3% (n = 137) by physicians only.
Malnutrition appears to be underdiagnosed by both RDNs and physicians. Underdiagnosis of malnutrition may have significant clinical, operational, and financial implications in cancer care.
癌症住院患者普遍存在营养不良问题,且营养不良会对临床结局产生不利影响。我们评估了入院时的营养不良风险、营养师识别的营养不良(DIMN)和医生诊断的营养不良(PDMN)的患病率。
本回顾性研究纳入了 2016 年 1 月至 2019 年 5 月期间在卡罗莱纳医疗保健公司阿特鲁姆健康中心(Atrium Health Carolinas Medical Center)就诊的 I-IV 期实体瘤恶性肿瘤成人患者。在入院过程中,注册护士使用营养不良筛查工具(MST)对患者进行评分,得分≥2 分即被认为存在营养不良风险。营养师对患者进行评估,以确定是否存在 DIMN 以及营养不良的严重程度(轻度、中度或重度)。出院小结中营养不良的国际疾病分类、第十版(ICD-10)编码被视为 PDMN。采用单变量模型进行估计,多变量逻辑回归模型采用逐步选择法识别与临床和人口统计学因素相关的营养不良患病率的关联。
共纳入 5143 例患者。中位年龄为 63(18-102)岁,48%为女性,70%为白人,24%为黑人。上消化道(21%)、胸部(18%)和泌尿生殖系统(18%)癌症最为常见。28%的患者患有 IV 期疾病。4085 例患者(79%)可获得 MST 评分,其中 1005 例(25%)存在营养不良风险。11%(n=557)的患者存在医生编码或营养师记录的营养不良;4%(n=223)的患者同时被医生和营养师识别,4%(n=197)仅被营养师识别,3%(n=137)仅被医生识别。
营养师和医生都可能存在营养不良的漏诊。营养不良的漏诊可能对癌症治疗的临床、运营和财务方面产生重大影响。